Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 18 Source: CRO
- €1.1 billion turnover
-
€43 million
profit - 385 employees
-
31st Dec 17 Source: CRO
- €491.6 million turnover
-
€1 million
profit - 300 employees
- 3 more years available »
Ranking
By Turnover
(€1.1 billion)- 90th in Top Companies
- 15th in Health
By Employees
(385)- 432nd in Top Companies
- 63rd in Health
- 385
- €1.1 billion
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- Jul 04 Nine more suing INM and Leslie Buckley over alleged data hacking
- Jul 04 Columbia Sportswear defies gloom with first Irish standalone shop
- Jul 04 Restaurants file court actions against insurers over lockdown losses
- Jul 03 European stocks pause as virus worries offset rebound hopes
- Jul 03 European stocks pause as coronavirus worries offset rebound hopes